Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
Retina regeneration
New HD lens
Glaucoma
Dry eye
Uveitis
Keratoconus


Survey

Are you in favour of stem cell technology?

93% Yes
7% No

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.

Click here to contact Neil Hanley, sales manager.

October 6, 2010


Investigating regenerative potential of retinal cells
Investigators from The Scripps Research Institute, and Thomas Reh, PhD from the University of Washington, received the highest possible scores for their proposal to investigate the regenerative potential of retinal cells, resulting in a $4.66 million NIH Transformative Award. Their long-term goal is to restore visual function lost through diseases such as macular degeneration and retinitis pigmentosa.. More...
First HD multifocal lens for presbyopia and astigmatism
Topcon has launched the LENTIS Mplustoric intraocular lens (IOL), designed to provide astigmatic patients the advanced benefits of Topcon's patented high-definition LENTIS Mplus technology. The company will officially present the lens to the market at the United Kingdom & Ireland Society of Cataract & Refractive Surgeons (UKISCRS) meeting in Brighton 11-12 November. More...
Collaboration on development and promotion of glaucoma treatment
Acucela and Otsuka Pharmaceutical have entered into a definitive agreement for the joint development and promotion of OPA-656, an adenosine A2a receptor agonist under development for treating glaucoma. More...
Product Profile
Carl Zeiss Meditec
IOLMaster® 500 - With automatic and non-contact measurement of the patient's eye, the new IOLMaster 500 offers the fastest and easiest way of calculating the right IOL for each patient.

Read more...
 
Coherent
Excimer lasers – Experience the material-friendly way of marking
Leading eye glass lens manufacturers continue moving their ophthalmic lens production to 193 nm excimer laser based marking and engraving for two reasons.


Read more...
Highlights of dry eye Phase 2 clinical study revealed
ISTA Pharmaceuticals has highlighted results from its Phase 2 clinical study on Remura dry eye solution. More...
FDA approval for non-infectious uveitis drug
Allergan has been given FDA approval for its drug Ozurdex (dexamethasone intravitreal implant) 0.7 mg for the treatment of non-infectious ocular inflammation. More...
Research study into treatment for keratoconus and corneal ectasia
A clinical trial is being conducted by the Cornea and Laser Eye Institute (CLEI) into the efficacy and safety of corneal collagen crosslinking (CXL) using riboflavin/dextran and hypotonic riboflavin in patients with progressive keratoconus and corneal ectasia. More...

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Advanstar House, Park West, Sealand Road, Chester, CH1 4RN United Kingdom